Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Frontiers in Oncology|February 7, 2019
A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study)Sadamoto Zenda, Yosuke Ota, Naomi Kiyota, et al.Auris, Nasus, Larynx|February 12, 2025
Risk factors for distant metastasis in papillary thyroid carcinoma: Association with lateral lymph node metastasisMasataka Nakamura, Nobuya Monden, Tomonori Terada, et al.Japanese Journal of Clinical Oncology|October 31, 2019
Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1)Yoshinori Imamura, Naomi Kiyota, Gakuto Ogawa, et al.Japanese Journal of Clinical Oncology|October 27, 2018
Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)Takashi Matsuzuka, Naomi Kiyota, Junki Mizusawa, et al.Ear, Nose, & Throat Journal|March 26, 2021
The Utility of Glasgow Prognostic Score and Palliative Prognostic Index in Patients With Head and Neck Squamous Cell Carcinoma Under Palliative CareTakehito Kishino, Terushige Mori, Takenori Miyashita, et al.Head & Neck|April 5, 2016
Association of impaired renal function and poor prognosis in oropharyngeal squamous cell carcinomaAkihiro Homma, Ryuichi Hayashi, Kazuyoshi Kawabata, et al.Japanese Journal of Clinical Oncology|March 13, 2013
Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trialTakayuki Yoshino, Yasuhisa Hasegawa, Shunji Takahashi, et al.Oral Oncology|April 15, 2014
The role of initial neck dissection for patients with node-positive oropharyngeal squamous cell carcinomasTomohiro Sakashita, Akihiro Homma, Ryuichi Hayashi, et al.International Journal of Clinical Oncology|July 26, 2012
Salvage surgery for recurrent oropharyngeal cancer after chemoradiotherapySatoshi Kano, Akihiro Homma, Ryuichi Hayashi, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 18, 2011
Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapySadamoto Zenda, Kazuto Matsuura, Hiroyuki Tachibana, et al.Pageof 5